Navigation Links
Anadys Pharmaceuticals to Report Third Quarter 2008 Financial Results
Date:10/16/2008

s, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 and ANA773 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. Risk factors that may cause actual results to differ are discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended June 30, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) today announced ... year ended October 31, 2009. Revenues for the fourth ... in the fourth quarter of fiscal 2008. Net income ... the fourth quarter of fiscal 2009, a 5% increase ... in last year,s fourth quarter. The fourth quarter ...
(Date:12/16/2009)... among the Best in the Nation ,, ... proudly announces it has been granted Magnet(R) recognition ... Recognition Program(R). Magnet(R) is one of the highest ... can achieve, and places Hahnemann among the five ... achieved this prestigious distinction. ,, At 9:00 am ...
(Date:12/16/2009)... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... ( http://www.cordblood-america.com ) focused on bringing the ... insurance policy, to families nationwide and internationally, said ... a total of $1.4 million so far in ... eliminated for the year now tops $10 million. ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3
... Endo Pharmaceuticals Inc. (Nasdaq: ENDP ), ... results on February 27, 2009 and will host ... that day to discuss these results. David P. ... Chief Operating Officer and Blaine Davis, Vice President, Corporate ...
... ETHEX Corporation, a,subsidiary of KV Pharmaceutical (NYSE: KVa/KVb), ... on January 26, 2009, a nationwide,voluntary recall of ... dates) at a wholesale or a retail level ... manufactured under conditions that did not,sufficiently comply with ...
... 21, Inc. (Nasdaq: NXXI ), a developer and ... levels, improve cardiovascular health, enhance memory and address chronic joint ... of the market - on Thursday, February 5, 2009 for ... 2008. The Company has scheduled a conference call to review ...
Other Biology Technology:Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009 2ETHEX Corporation Issues Nationwide Voluntary Recall of Products 2ETHEX Corporation Issues Nationwide Voluntary Recall of Products 3ETHEX Corporation Issues Nationwide Voluntary Recall of Products 4ETHEX Corporation Issues Nationwide Voluntary Recall of Products 5ETHEX Corporation Issues Nationwide Voluntary Recall of Products 6Nutrition 21 to Report Second Quarter Fiscal Year 2009 Financial Results on Thursday, February 5, 2009 2
(Date:12/16/2009)... Knowledge and Innovation Community (Climate-KIC)" is a major initiative ... program brings together the expertise of world class partners ... Europe,s innovation capacity to meet the climate change challenge ... a new low-carbon society. In responding to this challenge, ... produce, distribute, and consume goods, and to how we ...
(Date:12/16/2009)... Getting the most out of every drop of water is a ... summers are hot and dry and vines have to be irrigated ... found that a significant portion of the water applied to the ... "We found that about 10 percent of the water that is ... have contact with the soil and vine roots," said Eve Hinckley, ...
(Date:12/16/2009)... superstitions and rituals can help them get psyched up ... drugs (NSAIDs), which many athletes gobble down before and ... good. , "These agents are treatments for the symptoms ... Warden, whose research at Indiana University focuses on musculoskeletal ... to exercise or train at a certain level, but ...
Breaking Biology News(10 mins):Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4NSAIDs: Take 'em early and often when competing? Think again 2Marathon Health Expands Midwest Presence 53929 1Marathon Health Expands Midwest Presence 53929 2ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 13440 1ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 13440 2Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and 24200 Million Principal Amount of Convertib 13439 1Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and 24200 Million Principal Amount of Convertib 13439 2Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and 24200 Million Principal Amount of Convertib 13439 3
... Ohio and Michigan fruit and vegetable farms yield this ... eating choices of Latino migrant children for a Case ... will help migrant families understand why their children are ... to new interventions to combat this serious health issue., ...
... August 2008 - Disease Models & Mechanisms ( ... research and the use of model organisms to advance human ... is a highly anticipated biomedical research journal which officially ... at http://DMM.biologists.org . , DMM focuses on ...
... the world,s plant species rely on animals to transfer their ... pollinators is the bee, made up of about 30,000 species ... than half of the world,s flowering plants. In recent years, ... the U.S. and Europe has placed the health of ecosystems ...
Other Biology News:Case Western Reserve University study looks at keeping migrant workers' children healthy 2Building bridges between the clinic and the laboratory 2Saving our bees 2Saving our bees 3
... system uses the Adept CE 4100 high pressure ... UV/Visible detector for added flexibility and utra low ... alternative to a photodiode array detection and provides ... is required for method development and for monitoring ...
... This CLS number is a ... match Cornings product number. If showing ... the old Sigma-Aldrich number (E6152) or ... Comp Dim: H diam. 11.25 ...
... numbers of samples may be carried out using ... attention. System control and data processing is ... The elegant, powerful and very easy to ... 98 and 2000., The supplied detector is the ...
Mouse monoclonal antibody to QPCT - glutaminyl-peptide cyclotransferase (glutaminyl cyclase)...
Biology Products: